Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The Effect of Body Position on Measures of Arterial Stiffness in Humans.

Cohen J, Pignanelli C, Burr J.

J Vasc Res. 2020 Apr 1:1-9. doi: 10.1159/000506351. [Epub ahead of print]

PMID:
32235116
2.

Low-load resistance training to task failure with and without blood flow restriction: muscular functional and structural adaptations.

Pignanelli C, Petrick HL, Keyvani F, Heigenhauser GJF, Quadrilatero J, Holloway GP, Burr JF.

Am J Physiol Regul Integr Comp Physiol. 2020 Feb 1;318(2):R284-R295. doi: 10.1152/ajpregu.00243.2019. Epub 2019 Dec 11.

PMID:
31823670
3.

Evaluating the Anti-cancer Efficacy of a Synthetic Curcumin Analog on Human Melanoma Cells and Its Interaction with Standard Chemotherapeutics.

Parashar K, Sood S, Mehaidli A, Curran C, Vegh C, Nguyen C, Pignanelli C, Wu J, Liang G, Wang Y, Pandey S.

Molecules. 2019 Jul 6;24(13). pii: E2483. doi: 10.3390/molecules24132483.

4.

Blood flow restricted resistance exercise and reductions in oxygen tension attenuate mitochondrial H2 O2 emission rates in human skeletal muscle.

Petrick HL, Pignanelli C, Barbeau PA, Churchward-Venne TA, Dennis KMJH, van Loon LJC, Burr JF, Goossens GH, Holloway GP.

J Physiol. 2019 Aug;597(15):3985-3997. doi: 10.1113/JP277765. Epub 2019 Jul 7.

PMID:
31194254
5.

Corrigendum: Cancer Cell Mitochondria Targeting by Pancratistatin Analogs is Dependent on Functional Complex II and III.

Ma D, Pignanelli C, Tarade D, Gilbert T, Noel M, Mansour F, Adams S, Dowhayko A, Stokes K, Vshyvenko S, Collins J, Hudlicky T, McNulty J, Pandey S.

Sci Rep. 2018 Jul 4;8:46998. doi: 10.1038/srep46998.

6.

Cymbopogon citratus and Camellia sinensis extracts selectively induce apoptosis in cancer cells and reduce growth of lymphoma xenografts in vivo.

Philion C, Ma D, Ruvinov I, Mansour F, Pignanelli C, Noel M, Saleem A, Arnason J, Rodrigues M, Singh I, Ropat J, Pandey S.

Oncotarget. 2017 Nov 18;8(67):110756-110773. doi: 10.18632/oncotarget.22502. eCollection 2017 Dec 19.

7.

Exploiting mitochondrial and oxidative vulnerabilities with a synthetic analog of pancratistatin in combination with piperlongumine for cancer therapy.

Ma D, Gilbert T, Pignanelli C, Tarade D, Noel M, Mansour F, Gupta M, Ma S, Ropat J, Curran C, Vshyvenko S, Hudlicky T, Pandey S.

FASEB J. 2018 Jan;32(1):417-430. doi: 10.1096/fj.201700275R. Epub 2017 Sep 19.

PMID:
28928246
8.

Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs.

Pignanelli C, Ma D, Noel M, Ropat J, Mansour F, Curran C, Pupulin S, Larocque K, Wu J, Liang G, Wang Y, Pandey S.

Sci Rep. 2017 Apr 24;7(1):1105. doi: 10.1038/s41598-017-01230-4.

9.

Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest.

Tarade D, Ma D, Pignanelli C, Mansour F, Simard D, van den Berg S, Gauld J, McNulty J, Pandey S.

PLoS One. 2017 Mar 2;12(3):e0171806. doi: 10.1371/journal.pone.0171806. eCollection 2017.

10.

Cancer Cell Mitochondria Targeting by Pancratistatin Analogs is Dependent on Functional Complex II and III.

Ma D, Pignanelli C, Tarade D, Gilbert T, Noel M, Mansour F, Adams S, Dowhayko A, Stokes K, Vshyvenko S, Hudlicky T, McNulty J, Pandey S.

Sci Rep. 2017 Feb 21;7:42957. doi: 10.1038/srep42957. Erratum in: Sci Rep. 2018 Jul 04;8:46998.

Supplemental Content

Loading ...
Support Center